chr16-81035926-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_015251.3(ATMIN):āc.56C>Gā(p.Ala19Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000404 in 991,110 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_015251.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ATMIN | NM_015251.3 | c.56C>G | p.Ala19Gly | missense_variant | 1/4 | ENST00000299575.5 | |
CENPN-AS1 | XR_007065133.1 | n.87-1000G>C | intron_variant, non_coding_transcript_variant | ||||
CENPN-AS1 | XR_007065134.1 | n.3575+811G>C | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ATMIN | ENST00000299575.5 | c.56C>G | p.Ala19Gly | missense_variant | 1/4 | 1 | NM_015251.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000205 AC: 3AN: 146212Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.00000118 AC: 1AN: 844898Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 391474
GnomAD4 genome AF: 0.0000205 AC: 3AN: 146212Hom.: 0 Cov.: 32 AF XY: 0.0000281 AC XY: 2AN XY: 71088
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 16, 2022 | The c.56C>G (p.A19G) alteration is located in exon 1 (coding exon 1) of the ATMIN gene. This alteration results from a C to G substitution at nucleotide position 56, causing the alanine (A) at amino acid position 19 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at